They are generally downregulated in BLCA and a low expression of RNY1, 3 and 4 is associated with muscle invasiveness, lymph node metastases, advanced stage, and an unfavorable prognosis (Tolkach et al., 2017). The gene discussed is RNY1; the disease is bladder transitional cell carcinoma.